Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jens T Siveke
Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination With Trametinib in KRAS-mutant Pancreatic and Colorectal Cancer
Cancer Research
Cancer Research
Oncology
Extended RAS Analysis and Correlation With Overall Survival in Advanced Pancreatic Cancer
British Journal of Cancer
Cancer Research
Oncology
Related publications
Preclinical Activity of the Rational Combination of Selumetinib (AZD6244) in Combination With Vorinostat in KRAS-Mutant Colorectal Cancer Models
Clinical Cancer Research
Cancer Research
Oncology
LY3009120, a panRAF Inhibitor, Has Significant Anti-Tumor Activity in BRAF and KRAS Mutant Preclinical Models of Colorectal Cancer
Oncotarget
Oncology
Efficacy of a Covalent ERK1/2 Inhibitor, CC-90003, in KRAS Mutant Cancer Models Reveals Novel Mechanisms of Response and Resistance.
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Preclinical Efficacy of the Novel Competitive NAMPT Inhibitor STF-118804 in Pancreatic Cancer
Oncotarget
Oncology
Combination PI3K/MEK Inhibition Promotes Tumor Apoptosis and Regression in PIK3CA Wild-Type, KRAS Mutant Colorectal Cancer
Cancer Letters
Cancer Research
Oncology
Allosteric Inhibitors Target KRAS in a Mutant-Specific Manner
Cancer Discovery
Oncology
Safety and Efficacy of the Addition of Simvastatin to Cetuximab in Previously Treated KRAS Mutant Metastatic Colorectal Cancer Patients
Investigational New Drugs
Oncology
Pharmacology
New Strategies for Treatment of KRAS Mutant Metastatic Colorectal Cancer
Clinical Cancer Research
Cancer Research
Oncology
Trametinib With and Without Pazopanib Has Potent Preclinical Activity in Thyroid Cancer
Oncology Reports
Medicine
Cancer Research
Oncology
